875 related articles for article (PubMed ID: 32421155)
1. Planning for a COVID-19 Vaccination Program.
Schaffer DeRoo S; Pudalov NJ; Fu LY
JAMA; 2020 Jun; 323(24):2458-2459. PubMed ID: 32421155
[No Abstract] [Full Text] [Related]
2. Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.
Trogen B; Oshinsky D; Caplan A
JAMA; 2020 Jun; 323(24):2460-2461. PubMed ID: 32453392
[No Abstract] [Full Text] [Related]
3. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation.
COCONEL Group
Lancet Infect Dis; 2020 Jul; 20(7):769-770. PubMed ID: 32445713
[No Abstract] [Full Text] [Related]
4. Even covid-19 can't kill the anti-vaccination movement.
Megget K
BMJ; 2020 Jun; 369():m2184. PubMed ID: 32499217
[No Abstract] [Full Text] [Related]
5. Audio Interview: Guidelines for Covid-19 Vaccine Deployment.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Sep; 383(11):e88. PubMed ID: 32905696
[No Abstract] [Full Text] [Related]
6. Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust.
Schwartz JL
N Engl J Med; 2020 Oct; 383(18):1703-1705. PubMed ID: 32966716
[No Abstract] [Full Text] [Related]
7. The VACCINES Act: Deciphering Vaccine Hesitancy in the Time of COVID-19.
McAteer J; Yildirim I; Chahroudi A
Clin Infect Dis; 2020 Jul; 71(15):703-705. PubMed ID: 32282038
[TBL] [Abstract][Full Text] [Related]
8. Audio Interview: Covid-19 in Europe and New Information on Vaccines.
Rubin EJ; Baden LR; Haug CJ; Morrissey S
N Engl J Med; 2020 Nov; 383(21):e134. PubMed ID: 33207102
[No Abstract] [Full Text] [Related]
9. Preparing for the vaccine.
Nat Biotechnol; 2020 Nov; 38(11):1219. PubMed ID: 33110209
[TBL] [Abstract][Full Text] [Related]
10. Ensuring Uptake of Vaccines against SARS-CoV-2.
Mello MM; Silverman RD; Omer SB
N Engl J Med; 2020 Oct; 383(14):1296-1299. PubMed ID: 32589371
[No Abstract] [Full Text] [Related]
11. Russian SARS-CoV-2 vaccine.
Caddy S
BMJ; 2020 Aug; 370():m3270. PubMed ID: 32839191
[No Abstract] [Full Text] [Related]
12. Keeping track of the SARS-CoV-2 vaccine pipeline.
Parker EPK; Shrotri M; Kampmann B
Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
[TBL] [Abstract][Full Text] [Related]
13. Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2.
Plotkin SA
J Pediatric Infect Dis Soc; 2020 Nov; 9(5):517-518. PubMed ID: 32744616
[TBL] [Abstract][Full Text] [Related]
14. Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.
Wang EA; Zenilman J; Brinkley-Rubinstein L
JAMA; 2020 Sep; 324(11):1031-1032. PubMed ID: 32808972
[No Abstract] [Full Text] [Related]
15. Covid-19: Vaccine trials need more transparency to enable scrutiny and earn public trust, say experts.
Mahase E
BMJ; 2020 Oct; 371():m4042. PubMed ID: 33093065
[No Abstract] [Full Text] [Related]
16. Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19.
Coish JM; MacNeil AJ
Microbes Infect; 2020 Oct; 22(9):405-406. PubMed ID: 32590062
[TBL] [Abstract][Full Text] [Related]
17. Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency.
Avorn J; Kesselheim A
JAMA; 2020 Oct; 324(13):1284-1285. PubMed ID: 32870268
[No Abstract] [Full Text] [Related]
18. Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
McPartlin SO; Morrison J; Rohrig A; Weijer C
BMJ; 2020 Nov; 371():m4258. PubMed ID: 33168564
[No Abstract] [Full Text] [Related]
19. COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby.
Fujiwara K; Quinn MA
Int J Gynecol Cancer; 2020 Aug; 30(8):1255. PubMed ID: 32624498
[No Abstract] [Full Text] [Related]
20. Progress and Concept for COVID-19 Vaccine Development.
Wu SC
Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
[No Abstract] [Full Text] [Related]
[Next] [New Search]
